Square Pharmaceuticals PLC. reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was BDT 19,809.91 million compared to BDT 18,329.97 million a year ago. Revenue was BDT 17,229.05 million compared to BDT 15,887.36 million a year ago. Net income was BDT 4,922.73 million compared to BDT 4,283.04 million a year ago. Basic earnings per share from continuing operations was BDT 5.55 compared to BDT 4.83 a year ago.
For the nine months, sales was BDT 62,863.68 million compared to BDT 55,858.39 million a year ago. Revenue was BDT 54,207.2 million compared to BDT 48,144.07 million a year ago. Net income was BDT 16,168.09 million compared to BDT 14,909.53 million a year ago. Basic earnings per share from continuing operations was BDT 18.24 compared to BDT 16.82 a year ago.